loader
Please Wait
Applying Filters...
menu
    • menu

    Company Digital Content of Aucta Pharmaceuticals

    Aucta Pharmaceuticals-PSE
    News
    Aucta debuts generic Vimpat

    11 Mar 2024

    // DRUG STORE NEWS

    Aucta Pharmaceuticals Launches First Once-Daily Lacosamide Extended-Release Capsule

    26 Feb 2024

    // PR NEWSWIRE

    Aucta announced FDA approval of a generic version of Trileptal®(oxcarbazepine) oral suspension

    05 Dec 2022

    // PR NEWSWIRE

    Data Compilation
    #PharmaFlow

    Aucta Read More

    Contact Supplier

    Website

    CPhI Worldwide, Milan

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    Menu

    Aucta Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/aucta-pharmaceuticals-llc-party-content-46886.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/aucta-pharmaceuticals-llc-party-content-1623650142.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Aucta debuts generic Vimpat
    Aucta debuts generic Vimpat

    11 Mar 2024

    // DRUG STORE NEWS

    https://drugstorenews.com/aucta-debuts-generic-vimpat

    DRUG STORE NEWS
    11 Mar 2024
    Share Share
    Aucta Pharmaceuticals Launches First Once-Daily Lacosamide Extended-Release Capsule
    Aucta Pharmaceuticals Launches First Once-Daily Lacosamide Extended-Release Capsule

    26 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aucta-pharmaceuticals-inc-aucta-pharmaceuticals-launches-motpoly-xr-lacosamide-extended-release-capsules-c-v-the-first-and-only-once-daily-formulation-of-lacosamide-302070783.html

    PR NEWSWIRE
    26 Feb 2024
    Share Share
    Aucta announced FDA approval of a generic version of Trileptal®(oxcarbazepine) oral suspension
    Aucta announced FDA approval of a generic version of Trileptal®(oxcarbazepine) oral suspension

    05 Dec 2022

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aucta-announced-fda-approval-of-a-generic-version-of-trileptaloxcarbazepine-oral-suspension-301694327.html#:~:text=PISCATAWAY%2C%20N.J.%2C%20Dec.,this%20product%20in%20early%202023.

    PR NEWSWIRE
    05 Dec 2022
    Share Share
    Aucta announces FDA approval of a generic version of Perforomist Inhalation
    Aucta announces FDA approval of a generic version of Perforomist Inhalation

    01 Dec 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/aucta-announces-fda-approval-of-a-generic-version-of-perforomist-formoterol-fumarate-inhalation-solution-301691187.html

    PRNEWSWIRE
    01 Dec 2022
    Share Share
    Aucta's Generic Oxcarbazepine Receives Approval in the U.S.
    Aucta's Generic Oxcarbazepine Receives Approval in the U.S.

    30 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215332

    FDA
    30 Nov 2022
    Share Share
    Aucta's Generic Formoterol Fumarate Receives Approval in the U.S.
    Aucta's Generic Formoterol Fumarate Receives Approval in the U.S.

    25 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216486

    FDA
    25 Nov 2022
    Share Share